Low dose lenalidomide versus placebo in non-transfusion dependent patients with low risk, del(5q) myelodysplastic syndromes (SintraREV): a randomised, double-blind, phase 3 trial

  • María Díez-Campelo
  • , Félix López-Cadenas
  • , Blanca Xicoy
  • , Eva Lumbreras
  • , Teresa González
  • , Mónica del Rey González
  • , Joaquín Sánchez-García
  • , Rosa Coll Jordà
  • , Bohrane Slama
  • , Jose Ángel Hernández-Rivas
  • , Sylvain Thepot
  • , Teresa Bernal
  • , Agnès Guerci-Bresler
  • , Joan Bargay
  • , María Luz Amigo
  • , Claude Preudhomme
  • , Laurene Fenwarth
  • , Uwe Platzbecker
  • , Katharina S. Götze
  • , Ali Arar
    • Sofía Toribio, Consuelo Del Cañizo, Jesús María Hernández-Rivas, Pierre Fenaux

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Low dose lenalidomide versus placebo in non-transfusion dependent patients with low risk, del(5q) myelodysplastic syndromes (SintraREV): a randomised, double-blind, phase 3 trial'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science